遗传学
家族性高胆固醇血症
生物
外显子
突变
载脂蛋白B
基因
突变体
突变试验
低密度脂蛋白受体
基因突变
分子生物学
内分泌学
脂蛋白
胆固醇
作者
Margit Ebhardt,Hartmut Schmidt,Thilo Doerk,Uwe J.F. Tietge,Regina Haas,Michael-Peter Manns,Joerg Schmidtke,Manfred Stuhrmann
标识
DOI:10.1002/(sici)1098-1004(1999)13:3<257::aid-humu14>3.3.co;2-4
摘要
In order to obtain a survey of the mutations being prevalent in Northern Germany and to enable molecular genetic testing for families with clinically diagnosed familial hypercholesterolemia (FH), we screened 46 unrelated German individuals with elevated LDL levels for mutations in the 18 exons and their flanking intron sequences including the promotor region of the LDL receptor (LDLR) gene. In addition, we tested all patients for the presence of mutations in the gene coding for apolipoprotein B-100 (apoB-100). We detected 15 mutations affecting the LDLR gene, 8 of which, designated A29S, 195insAT, 313+1insG, 553insG, 680insGGACAAATCTG, D200N, E267K and L411V have not yet been reported. One patient is heterozygous for the double mutant N543H and 2393del9Bp. Two patients carried the mutation R3500Q (Arg→Glu) within the apoB-100 gene. © 1999 Wiley-Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI